• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy

by December 16, 2024
written by December 16, 2024

Investing.com — Jefferies upgraded Bristol-Myers Squibb Company (NYSE:BMY) to “buy” from “hold” and raised its price target by $7 to $70, amid an improved confidence in the company’s product pipeline, disciplined spending, and greater clarity on regulatory risks.

The brokerage highlighted the potential of BMY’s schizophrenia drug, Cobenfy, forecasting it to become a $10 billion-plus product.

Jefferies noted positive momentum from recent launches, including Cobenfy’s label hitting best-case scenarios, and projected stronger-than-expected sales for 2024 and 2025.

It also expressed optimism about Cobenfy’s Alzheimer’s psychosis trials, assigning a 70% probability of success for a key Phase 3 study, and pointed to the drug’s potential efficacy in bipolar disorder, with trials expected to begin in mid-2025.

Bristol Myers remains exposed to loss of exclusivity risks for over 70% of its revenues, but Jefferies said the company’s improved visibility on financial performance and promising pipeline justified the upgrade.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump signals potential reconsideration of TikTok ban
next post
Shein weighs sale of less than 10% of company in London IPO, sources say

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 5, 2025
    • This California startup is cleaning water and removing CO₂ from the atmosphere — all at a reduced cost

      June 5, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (504)
    • Stock (6,426)

    Latest News

    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

    Popular News

    • Volkswagen shares fall as markets struggles to digest unions deal
    • Spanish leader’s opponents say ‘xenophobic’ foreign homebuyer tax will not be applied

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy